Michael D Prados

Michael D Prados

UNVERIFIED PROFILE

Are you Michael D Prados?   Register this Author

Register author
Michael D Prados

Michael D Prados

Publications by authors named "Michael D Prados"

Are you Michael D Prados?   Register this Author

100Publications

3141Reads

21Profile Views

Attitudes toward fertility and fertility preservation in women with glioma.

Neurooncol Pract 2019 May 26;6(3):218-225. Epub 2018 Sep 26.

Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/nop/npy036DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6656302PMC
May 2019

Using genomics to guide treatment for glioblastoma.

Pharmacogenomics 2018 10 11;19(15):1217-1229. Epub 2018 Sep 11.

Department of Neurological Surgery, University of California, San Francisco, CA 94143, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/pgs-2018-0078DOI Listing
October 2018

Phase II study of cabozantinib in patients with progressive glioblastoma: subset analysis of patients naive to antiangiogenic therapy.

Neuro Oncol 2018 01;20(2):249-258

Center for Neuro-Oncology, Dana-Farber/Brigham & Women's Cancer Center, Boston, Massachusetts (P.Y.W, J.D.); The University of Texas MD Anderson Cancer Center, Houston, Texas (J.dG.); University of California, San Francisco, Helen Diller Cancer Center Building, San Francisco, California (M.D.P.); Duke University, Durham, North Carolina (D.A.R., A.D.); Neuro-Oncology Center, University of Virginia Health System, Charlottesville, Virginia (D.S.); University of Washington, Department of Neurology, Fred Hutchinson Cancer Research Center, Seattle, Washington (M.C.); Henry Ford Health System, Detroit, Michigan (T.M.); Exelixis, South San Francisco, California (J.H., J.P., R.W.); The Ronald Reagan UCLA Medical Center, Los Angeles, California (T.F.C.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nox154DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5777496PMC
January 2018

Phase II study of cabozantinib in patients with progressive glioblastoma: subset analysis of patients with prior antiangiogenic therapy.

Neuro Oncol 2018 01;20(2):259-267

The Ronald Reagan UCLA Medical Center, Los Angeles, California (T.F.C.); Center for Neuro-Oncology, Dana-Farber/Brigham & Women's Cancer Center, Boston, Massachusetts (P.Y.W., J.D.); The University of Texas MD Anderson Cancer Center, Houston, Texas (J.dG.); University of California San Francisco, San Francisco, California (M.D.P.); Duke University, Durham, North Carolina (D.A.R., A.D.); Neuro-Oncology Center, University of Virginia Health System, Charlottesville, Virginia (D.S.); University of Washington, Department of Neurology, Fred Hutchinson Cancer Research Center, Seattle, Washington (M.C.); Henry Ford Health System, Detroit, Michigan (T.M.); Exelixis, South San Francisco, California (J.P., J.H., R.W.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nox151DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5777491PMC
January 2018

A phase 1 trial of intravenous liposomal irinotecan in patients with recurrent high-grade glioma.

Cancer Chemother Pharmacol 2017 03 23;79(3):603-610. Epub 2017 Feb 23.

Division of Neuro-oncology, Department of Neurological Surgery, University of California, San Francisco (UCSF), 505 Parnassus Avenue M779, San Francisco, CA, 94143, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-017-3247-3DOI Listing
March 2017

Inhibition of DNA damage repair by the CDK4/6 inhibitor palbociclib delays irradiated intracranial atypical teratoid rhabdoid tumor and glioblastoma xenograft regrowth.

Neuro Oncol 2016 11 1;18(11):1519-1528. Epub 2016 Jul 1.

Department of Neurological Surgery, Feinberg School of Medicine, Northwestern University, Chicago, Illinois (R.H., A.Z., C.D.J., A.M.S., C.H.); Department of Biochemistry and Molecular Genetics, Feinberg School of Medicine, Northwestern University, Chicago, Illinois (R.H., C.D.J.); Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois (A.H.S., S.-Y.C.), Northwestern Brain Tumor Institute, Feinberg School of Medicine, Northwestern University, Chicago, Illinois (R.H., R.R.L., S.G., A.M.S., A.P.M., A.H.S., S.-Y.C., C.H., C.D.J.); Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, Illinois (R.H., R.R.L., S.G., A.P.M., A.H.S., S.-Y.C., C.H., C.D.J.); Chemistry of Life Processes Institute, Northwestern University, Evanston, Illinois (A.P.M., C.D.J.); Department of Pediatrics, Division of Hematology/Oncology, Ann and Robert H. Lurie Children's Hospital, Chicago, Illinois (R.R.L., S.G.); Department of Neurological Surgery, University of California San Francisco, San Francisco, California (S.M., M.D.P.); Department of Pediatrics, University of California San Francisco, San Francisco, California (S.M.); Department of Radiation Oncology, Brigham and Women's Hospital, Boston, Massachusetts (D.A.H.-K.); Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota (J.N.S.); Lombardi Cancer Center, Georgetown University, Washington, DC (T.W.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/now106DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5063519PMC
November 2016

Clinical outcome and prognostic factors for central neurocytoma: twenty year institutional experience.

J Neurooncol 2016 Jan;126(1):193-200

Department of Radiation Oncology, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Boston Children's Hospital, Harvard Medical School, 450 Brookline Ave, D1622, Boston, MA, 02215-5418, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-015-1959-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826306PMC
January 2016

The Effect of Timing of Concurrent Chemoradiation in Patients With Newly Diagnosed Glioblastoma.

Neurosurgery 2015 Aug;77(2):248-53; discussion 253

Departments of *Neurological Surgery, ‡Epidemiology and Biostatistics, and §Neurology, University of California at San Francisco, San Francisco, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1227/NEU.0000000000000766DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4506198PMC
August 2015

Toward precision medicine in glioblastoma: the promise and the challenges.

Neuro Oncol 2015 Aug 1;17(8):1051-63. Epub 2015 May 1.

University of California San Francisco, San Francisco, California (M.D.P, J.J.P., A.M.M., S.M.C.); Translational Genomics Research Institute, Phoenix, Arizona (S.A.B., N.L.T., W.D.T., J.A.K., M.E.B., D.W.C., J.D.C., J.M.T.); Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts (K.L.L., P.Y.W.); University of Texas Health Science Center, San Antonio, Texas (J.G.K.); Memorial Sloan-Kettering Cancer Center, New York, New York (I.K.M.); The University of Texas M.D. Anderson Cancer Center, Houston, Texas (J.F.d.G.); University of Utah Huntsman Cancer Institute, Salt Lake City, Utah (H.C.); University of California Los Angeles, Los Angeles, California (T.F.C.); Iowa Spine and Brain Institute, Waterloo, Iowa (T.C.R.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nov031DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4490873PMC
August 2015

Vismodegib Exerts Targeted Efficacy Against Recurrent Sonic Hedgehog-Subgroup Medulloblastoma: Results From Phase II Pediatric Brain Tumor Consortium Studies PBTC-025B and PBTC-032.

J Clin Oncol 2015 Aug 13;33(24):2646-54. Epub 2015 Jul 13.

Giles W. Robinson, Brent A. Orr, Gang Wu, Tong Lin, Ibrahim Qaddoumi, Sue C. Kaste, Michael Rusch, Sariah J. Allen, Arzu Onar-Thomas, Clinton F. Stewart, James M. Boyett, Richard J. Gilbertson, David W. Ellison, and Amar Gajjar, St Jude Children's Research Hospital, Memphis, TN; Sridharan Gururangan and Annick Desjardins, Duke University Medical Center, Durham, NC; Roger J. Packer, Children's National Medical Center, Washington, DC; Stewart Goldman, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, IL; Michael D. Prados, University of California San Francisco, San Francisco, CA; Murali Chintagumpala, Texas Children's Cancer Center, Houston, TX; Naoko Takebe, National Cancer Institute, Bethesda, MD; Maryam Fouladi, Cincinnati Children's Hospital, Cincinnati, OH; and Tom Curran, Children's Hospital of Philadelphia, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.60.1591DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4534527PMC
August 2015

Impact of Timing of Concurrent Chemoradiation for Newly Diagnosed Glioblastoma: A Critical Review of Current Evidence.

Neurosurgery 2015 Aug;62 Suppl 1:160-5

*Department of Neurological Surgery, ‡Department of Epidemiology and Biostatistics, and §Department of Neurology, University of California, San Francisco, San Francisco, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1227/NEU.0000000000000801DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5260825PMC
August 2015

Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors.

N Engl J Med 2015 Jun 10;372(26):2499-508. Epub 2015 Jun 10.

From the Departments of Health Sciences Research (J.E.E.-P., P.A.D., H.S., M.L.K.), Laboratory Medicine and Pathology (D.H.L., G.S., A.A.C., T.M.K., C.E.P., A.R.C., C.H., C.G., R.B.J.), Neurology (D.H.L., B.P.O.), and Oncology (J.C.B.), Mayo Clinic, Rochester, MN; the Departments of Neurological Surgery (A.M.M., K.M.W., T.R., I.V.S., H.M.H., L.S.M., S.Z., A.P., M.S.B., S.M.C., M.D.P., J.K.W., M.R.W.), Epidemiology and Biostatistics (A.M.M., P.M.B., J.W., J.K.W., M.R.W.) and Pathology (M.P., R.M., G.F.R., A.P., T.T.) and the Institute of Human Genetics (J.W., J.K.W., M.R.W.), University of California, San Francisco, and the Bioinformatics Core, Gladstone Institutes (A.R.P.) - all in San Francisco; and the Department of Pathology and Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York (J.T.H.).

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/10.1056/NEJMoa1407279
Publisher Site
http://dx.doi.org/10.1056/NEJMoa1407279DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4489704PMC
June 2015

Brain Malignancy Steering Committee clinical trials planning workshop: report from the Targeted Therapies Working Group.

Neuro Oncol 2015 Feb 26;17(2):180-8. Epub 2014 Aug 26.

Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts (B.M.A., L.T., K.L.L., P.Y.W.); Mayo Clinic, Rochester, Minnesota (E.G., K.V.B., B.P.O., J.N.S.); The University of Texas M.D. Anderson Cancer Center, Houston, Texas (W.K.A.Y., J.F.D., D.A.B.); St. Jude Children's Research Hospital, Memphis, Tennessee (J.M.B.); University of California, Los Angeles, California (T.F.C.); Memorial Sloan-Kettering Cancer Center, New York, New York (J.T.H., I.K.M.); National Cancer Institute, Bethesda, Maryland (B.M., A.T.-A.); Princess Margaret Cancer Centre, Toronto, Ontario, Canada (W.M.); Henry Ford Hospital, Detroit, Michigan (T.M.); University of California, San Diego, La Jolla, California (P.S.M.); University of California, San Francisco, California (M.D.P.); Johns Hopkins University, Baltimore, Maryland (X.Y.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nou154DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288520PMC
February 2015

Familial gliomas: cases in two pairs of brothers.

J Neurooncol 2015 Jan 11;121(1):135-40. Epub 2014 Sep 11.

Department of Neurological Surgery, University of California, San Francisco, 505 Parnassus Ave., Rm M779, San Francisco, CA, 94143-0112, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-014-1611-2DOI Listing
January 2015

Report of the Jumpstarting Brain Tumor Drug Development Coalition and FDA clinical trials neuroimaging endpoint workshop (January 30, 2014, Bethesda MD).

Neuro Oncol 2014 Oct;16 Suppl 7:vii36-47

Center for Neuro-Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts (P.Y.W., D.A.R.); University of California, Los Angeles School of Medicine, Los Angeles, California (T.F.C., B.M.E., W.B.P.); New York University Langone Medical Center, New York, New York (H.A.F.); Hoffmann-La Roche, Basel, Switzerland (L.A.); Department of Biostatistics, Mayo Clinic Rochester, Rochester, Minnesota (K.B.); Department of Neuro-radiology, University of Heidelberg, Heidelberg, Germany (M.B.); Department of Medical Oncology, Mayo Clinic Rochester, Rochester, Minnesota (J.B.); Brain Tumor Center, University of California, San Francisco, California (S.M.C., M.D.P.); Siemens Healthcare North America, Malvern, Pennsylvania (A.G.S.); Department of Neuro-Oncology, Erasmus M.C.-Daniel den Hoed Cancer Center, Rotterdam, Netherlands (M.v.d.B.); Department of Neuro-Oncology, M.D. Anderson Cancer Center, Houston, Texas (W-K.A.Y.).

View Article

Download full-text PDF

Source
https://academic.oup.com/neuro-oncology/article-lookup/doi/1
Publisher Site
http://dx.doi.org/10.1093/neuonc/nou226DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4195530PMC
October 2014

Phase II trial of 7 days on/7 days off temozolmide for recurrent high-grade glioma.

Neuro Oncol 2014 Sep 26;16(9):1255-62. Epub 2014 Mar 26.

Department of Neurological Surgery, University of California, San Francisco, California (S.J.H., J.D.R., A.M.M., J.L.C., M.D.P., S.M.C., M.S.B., A.D., N.A.B.); Department of Epidemiology and Biostatistics, University of California, San Francisco, California (A.M.M.).

View Article

Download full-text PDF

Source
https://academic.oup.com/neuro-oncology/article-lookup/doi/1
Publisher Site
http://dx.doi.org/10.1093/neuonc/nou044DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4136897PMC
September 2014

Plexiform neurofibromas, trial design, and the definitions of "progression" and "treatment failure".

Authors:
Michael D Prados

Neuro Oncol 2014 May 8;16(5):617-8. Epub 2014 Apr 8.

University of California San Francisco, Department of Neurological Surgery, Neuro-Oncology Service, 400 Parnassus, Room A-808, San Francisco, California 94143-0372.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nou050DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3984566PMC
May 2014

Phase I/II study of erlotinib and temsirolimus for patients with recurrent malignant gliomas: North American Brain Tumor Consortium trial 04-02.

Neuro Oncol 2014 Apr 26;16(4):567-78. Epub 2014 Jan 26.

Center for Neuro-Oncology, Dana Farber/Brigham and Women's Cancer Center, Boston, Massachusetts (P.Y.W., A.D.N., J.D.); Department of Neurosurgery, University of California, San Francisco, San Francisco, California (S.M.C., K.R.L., M.D.P.); University of Texas Health Science Center, San Antonio, Texas (J.G.K.); Division of Neuro-Oncology, Department of Neurology, University of California, Los Angeles, Los Angeles, California (T.F.C.); University of Wisconsin, Madison Wisconsin (H.I.R., M.P.M.); Neurooncology Program, Division of Hematology/Oncology, University of Pittsburgh Medical Center Cancer Pavilion, Pittsburgh, Pennsylvania (F.S.L.); Division of Neuro-Oncology, MD Anderson Cancer Center, Houston, Texas (M.R.G., M.D.G., W.K.A.Y., K.D.A.); Center for Molecular Oncologic Pathology, Dana Farber/Brigham and Women's Cancer Center, Boston, Massachusetts (S.S., A.H.L.); Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts (S.S., A.H.L., K.L.L.); Investigational Drug Branch, Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, Maryland (J.D.*, J.J.W.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/not247DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3956354PMC
April 2014

"We will know it when we see it;" bevacizumab and glioblastoma.

Authors:
Michael D Prados

Neuro Oncol 2014 Apr;16(4):469-70

University of California San Francisco, Department of Neurological Surgery, Neuro-Oncology Service, 400 Parnassus, Room A-808, San Francisco, CA 94143-0372.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nou036DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3956364PMC
April 2014

Targeting Wee1 for the treatment of pediatric high-grade gliomas.

Neuro Oncol 2014 Mar 4;16(3):352-60. Epub 2013 Dec 4.

Department of Neurology, University of California, San Francisco, San Francisco, California (S.M., I.K.); Department of Pediatrics, University of California, San Francisco, San Francisco, California (S.M., M.D.P., N.G.); Brain Tumor Research Center, University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California (S.M., R.H., X.Y., A.K.O., J.P., M.W.T., C.D.J., M.S.B., N.G., D.A.H.-K.); Department of Neurological Surgery, University of California, San Francisco, San Francisco, California (S.M., J.P., I.S., M.D.P., C.D.J., M.S.B., N.G., D.A.H.-K.); Department of Radiation Oncology, University of California, San Francisco, San Francisco, California (D.A.H.-K.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/not220DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3922515PMC
March 2014

Heat-shock protein peptide complex-96 vaccination for recurrent glioblastoma: a phase II, single-arm trial.

Neuro Oncol 2014 Jan 12;16(2):274-9. Epub 2013 Dec 12.

Corresponding Author: Andrew T. Parsa, MD, PhD, Professor and Chair, Department of Neurological Surgery, Northwestern University, Feinberg School of Medicine, 676 N. St. Clair Street, Suite 2210, Chicago, IL 60611.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/not203DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3895386PMC
January 2014

Gliosarcoma arising from an oligodendroglioma (oligosarcoma).

Clin Neuropathol 2013 May-Jun;32(3):165-70

Department of Pathology, University of California San Francisco, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5414/NP300577DOI Listing
June 2013

Neurosurgical management and prognosis of patients with glioblastoma that progresses during bevacizumab treatment.

Neurosurgery 2012 Feb;70(2):361-70

Department of Neurological Surgery, University of California, San Francisco, San Francisco, California 94143-0112, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1227/NEU.0b013e3182314f9dDOI Listing
February 2012

Pediatric intracranial ependymoma: the roles of surgery, radiation and chemotherapy.

J Neurooncol 2012 Jan 9;106(2):367-75. Epub 2011 Aug 9.

Department of Radiation Oncology, University of California, San Francisco and UCSF Benioff Children's Hospital, 1600 Divisadero Street, Suite H1031, San Francisco, CA 94115-1708, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007%252Fs11060-011-
Web Search
http://link.springer.com/10.1007/s11060-011-0671-9
Publisher Site
http://dx.doi.org/10.1007/s11060-011-0671-9DOI Listing
January 2012

Investigation of intravenous delivery of nanoliposomal topotecan for activity against orthotopic glioblastoma xenografts.

Neuro Oncol 2011 Dec 27;13(12):1288-95. Epub 2011 Sep 27.

Department of Neurological Surgery, University of California-San Francisco, 1450 Third St, San Francisco, CA 94158, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nor139DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3223095PMC
December 2011

Recurrent asymptomatic demyelinating disease following 13-cis-retinoic acid exposure.

BMJ Case Rep 2009 8;2009. Epub 2009 Sep 8.

University of California, San Francisco, Neurology, Suite 908, UCSF Multiple Sclerosis Center, 350 Parnassus Avenue, San Francisco, CA 94117, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/bcr.05.2009.1908DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3029989PMC
November 2011

Impact of bevacizumab chemotherapy on craniotomy wound healing.

J Neurosurg 2011 Jun 10;114(6):1609-16. Epub 2010 Dec 10.

Department of Neurological Surgery, University of California, San Francisco, California 94143-0112, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3171/2010.10.JNS101042DOI Listing
June 2011

A phase I/II trial of the histone deacetylase inhibitor romidepsin for adults with recurrent malignant glioma: North American Brain Tumor Consortium Study 03-03.

Neuro Oncol 2011 May 3;13(5):509-16. Epub 2011 Mar 3.

Neuro-Oncology Branch, National Cancer Institute, National Institute of Neurological Disorder and Stroke, National Institutes of Health, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nor017DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3093337PMC
May 2011

Phase II TPDCV protocol for pediatric low-grade hypothalamic/chiasmatic gliomas: 15-year update.

J Neurooncol 2010 Oct 11;100(1):121-7. Epub 2010 Mar 11.

Department of Radiation Oncology, University of California, San Francisco, 1600 Divisadero, San Francisco, CA 94143, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-010-0151-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2951507PMC
October 2010

Enzastaurin plus temozolomide with radiation therapy in glioblastoma multiforme: a phase I study.

Neuro Oncol 2010 Jun 15;12(6):608-13. Epub 2010 Feb 15.

Department of Neurological Surgery, University of California San Francisco, 400 Parnassus Avenue, A808, San Francisco, CA 94143-0350, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nop070DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2940647PMC
June 2010

Morphologic and molecular characterization of ATRT xenografts adapted for orthotopic therapeutic testing.

Neuro Oncol 2010 Apr 11;12(4):366-76. Epub 2010 Jan 11.

Brain Tumor Research Center, Department of Neurological Surgery, University ofCalifornia, San Diego, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nop033DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2940601PMC
April 2010

Pharmacologic inhibition of cyclin-dependent kinases 4 and 6 arrests the growth of glioblastoma multiforme intracranial xenografts.

Cancer Res 2010 Apr 30;70(8):3228-38. Epub 2010 Mar 30.

Department of Neurological Surgery, Helen Diller Comprehensive Cancer Center, University of California San Francisco, California 94143-0520, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-09-4559DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2855904PMC
April 2010

Clinical characteristics and outcomes for a modern series of primary gliosarcoma patients.

Cancer 2010 Mar;116(5):1358-66

Department of Neurological Surgery, University of California, San Francisco, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.24857DOI Listing
March 2010

Primary gliosarcoma: key clinical and pathologic distinctions from glioblastoma with implications as a unique oncologic entity.

J Neurooncol 2010 Feb 18;96(3):313-20. Epub 2009 Jul 18.

Department of Neurological Surgery, University of California at San Francisco, 505 Parnassus Ave., San Francisco, CA 94117, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-009-9973-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2808523PMC
February 2010

Joint NCCTG and NABTC prognostic factors analysis for high-grade recurrent glioma.

Neuro Oncol 2010 Feb 21;12(2):164-72. Epub 2009 Dec 21.

Division of Biostatistics, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nop019DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2940570PMC
February 2010

A human brainstem glioma xenograft model enabled for bioluminescence imaging.

J Neurooncol 2010 Jan 8;96(2):151-9. Epub 2009 Jul 8.

Department of Neurological Surgery, Brain Tumor Research Center, University of California, 505 Parnassus Ave., Room M779, San Francisco, CA 94143-0112, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-009-9954-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2808534PMC
January 2010

Spinal cord oligodendroglioma with 1p and 19q deletions presenting with cerebral oligodendrogliomatosis.

J Neurosurg Spine 2009 Jun;10(6):557-63

Department of Neurosurgery, The Kaiser Permanente Medical Group, and University of California, San Francisco, Sacramento, California 95825-2115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3171/2009.2.SPINE08853DOI Listing
June 2009

Radiation is an important component of multimodality therapy for pediatric non-pineal supratentorial primitive neuroectodermal tumors.

Int J Radiat Oncol Biol Phys 2008 Dec 15;72(5):1319-23. Epub 2008 May 15.

Department of Radiation Oncology, University of California-San Francisco, San Francisco, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2008.03.033DOI Listing
December 2008

Preoperative prognostic classification system for hemispheric low-grade gliomas in adults.

J Neurosurg 2008 Nov;109(5):817-24

Brain Tumor Research Center, Department of Neurological Surgery, University of California, San Francisco, California 94143, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3171/JNS/2008/109/11/0817DOI Listing
November 2008

Phase-1 trial of gefitinib and temozolomide in patients with malignant glioma: a North American brain tumor consortium study.

Cancer Chemother Pharmacol 2008 May 11;61(6):1059-67. Epub 2007 Aug 11.

Department of Neurological Surgery, University of California San Francisco, 400 Parnassus Ave., Room 808, San Francisco, CA 94143-0372, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-007-0556-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3873156PMC
May 2008

Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas.

J Clin Oncol 2008 Mar;26(8):1338-45

Department of Neurological Surgery, Brain Tumor Research Center, University of California San Francisco, 505 Parnassus Ave, Room M-779, San Francisco, CA 94143-0112, USA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2007.13.9337
Publisher Site
http://dx.doi.org/10.1200/JCO.2007.13.9337DOI Listing
March 2008

Phase I trial of gross total resection, permanent iodine-125 brachytherapy, and hyperfractionated radiotherapy for newly diagnosed glioblastoma multiforme.

Int J Radiat Oncol Biol Phys 2007 Nov 23;69(3):825-30. Epub 2007 May 23.

Department of Radiation Oncology, University of California, San Francisco School of Medicine, San Francisco, CA 94143-0226, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2007.03.061DOI Listing
November 2007

Historical controls for phase II surgically based trials requiring gross total resection of glioblastoma multiforme.

J Neurooncol 2007 Oct 25;85(1):87-94. Epub 2007 Apr 25.

Neuro-Oncology Service, Department of Neurological Surgery, University of California, San Francisco, 400 Parnassus Avenue, A808, San Francisco, CA 94143-0350, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11060-007-9388-1
Publisher Site
http://dx.doi.org/10.1007/s11060-007-9388-1DOI Listing
October 2007